|
|
| Year:
2017 |
Month:
October
|
Volume:
6 |
Issue:
4 |
Page:
BO22 - BO24 |
Evaluation of Vitamin D in Breast Cancer in a Tertiary Care Hospital
|
| |
Correspondence
MN Suma, Swetha NK, Parveen Doddamani, Binay Kumar Yadav, Akash R,
Dr. Swetha NK,
Assistant Professor, Department of Biochemistry,
JSS Medical College, JSS University,
Mysuru-570015, Karnataka, India.
E-mail: drswethasuresh@gmail.com :
|
 |
Introduction: Vitamin D has been implicated to play a very important role in different types of cancers due to its pleotropic effects such as cell proliferation, cell differentiation, apoptosis etc. The implications of vitamin D deficiency are more evident in breast, prostate and colorectal cancer. Studies have revealed vitamin D supplementation reduces the risk of Breast cancer.
Aim: The main objective of our study was to find out whether low serum 25-hydroxy vitamin D levels was associated with breast cancer.
Materials and Methods: Study group included 25 diagnosed cases of breast cancer. Equal number of age and sex matched healthy persons were included in the control group. Serum 25-hydroxy vitamin D was estimated by electrochemiluminiscence immunoassay.
Results: Mean vitamin D levels were low in breast cancer patients, when compared to controls (p-value < 0.05),which shows that low vitamin D levels are associated with increased risk of breast cancer.
Conclusion: Our study showed that low levels of vitamin D are associated with breast cancer when compared to apparently healthy controls. Estimation of serum vitamin D in patients with breast cancer might help in the early diagnosis and treatment of breast cancer.
|
| |
[ FULL
TEXT ] | [   ]
|
| |
Print
|
|